URBANSKI RAYMOND W. (CEO) sold 11.6% of their position (176.98K shares) of GT BIOPHARMA, INC. on the open market
Open‑market sale worth $176.98 — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/19/2019ACC: 0000939798-19-000008
DirectorOfficer· CEO
Since Feb 2019
-176.98K
Net shares
Net seller
$176.98
Total sold
1
Open market trades
0B · 1S
1
Total transactions
176.98K disposed
Non-Derivative Transactions1
common stock
Direct
Shares
−176.98K
Price / share
$0.00
Trade value
$176.98
% of position
11.6%
2/1/2019
1.53M→1.35M
Total
Net shares
−176.98K
Net value
-$176.98
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| common stock Direct | 2/1/2019 | S · Sale | −176.98K | $0.00 | $176.98 | 11.6% | 1.53M | 1.35M |
| Total | −176.98K | -$176.98 | ||||||
Derivative Transactions0
No derivative transactions reported